164 related articles for article (PubMed ID: 32698456)
1. Comparative Analyses of the Antiviral Activities of IgG and IgA Antibodies to Influenza A Virus M2 Protein.
Okuya K; Eguchi N; Manzoor R; Yoshida R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Miyamoto H; Ichii O; Kajihara M; Higashi H; Takada A
Viruses; 2020 Jul; 12(7):. PubMed ID: 32698456
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
3. A Novel Mechanism Underlying Antiviral Activity of an Influenza Virus M2-Specific Antibody.
Manzoor R; Eguchi N; Yoshida R; Ozaki H; Kondoh T; Okuya K; Miyamoto H; Takada A
J Virol; 2020 Dec; 95(1):. PubMed ID: 33055251
[TBL] [Abstract][Full Text] [Related]
4. Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity.
Muramatsu M; Yoshida R; Yokoyama A; Miyamoto H; Kajihara M; Maruyama J; Nao N; Manzoor R; Takada A
PLoS One; 2014; 9(1):e85582. PubMed ID: 24465606
[TBL] [Abstract][Full Text] [Related]
5. [In vitro Antiviral Activity of Recombinant Antibodies of IgG and IgA Isotypes to Hemagglutinin of the Influenza A Virus].
Argentova VV; Aliev TK; Zarubaev VV; Klotchenko SA; Shtro AA; Sergeeva MV; Toporova VA; Dolgikh DA; Sveshnikov PG; Vasin VA; Kirpichnikov MP
Mol Biol (Mosk); 2017; 51(6):927-937. PubMed ID: 29271957
[TBL] [Abstract][Full Text] [Related]
6. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies.
Mazanec MB; Coudret CL; Fletcher DR
J Virol; 1995 Feb; 69(2):1339-43. PubMed ID: 7815518
[TBL] [Abstract][Full Text] [Related]
7. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.
Tamura S; Funato H; Hirabayashi Y; Kikuta K; Suzuki Y; Nagamine T; Aizawa C; Nakagawa M; Kurata T
Vaccine; 1990 Oct; 8(5):479-85. PubMed ID: 2251874
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of an M2-specific monoclonal antibody on different strains of influenza A virus.
Muto NA; Yoshida R; Suzuki T; Kobayashi S; Ozaki H; Fujikura D; Manzoor R; Muramatsu M; Takada A; Kimura T; Sawa H
Jpn J Vet Res; 2012 Aug; 60(2-3):71-83. PubMed ID: 23094582
[TBL] [Abstract][Full Text] [Related]
9. Colocalization of intracellular specific IgA (icIgA) with influenza virus in patients' nasopharyngeal aspirate cells.
Kok TW; Costabile M; Tannock GA; Li P
J Virol Methods; 2018 Feb; 252():8-14. PubMed ID: 29102516
[TBL] [Abstract][Full Text] [Related]
10. Recombinant immunoglobulin A specific for influenza A virus hemagglutinin: production, functional analysis, and formation of secretory immunoglobulin A.
Shoji K; Takahashi T; Kurohane K; Iwata K; Matsuoka T; Tsuruta S; Sugino T; Miyake M; Suzuki T; Imai Y
Viral Immunol; 2015 Apr; 28(3):170-8. PubMed ID: 25658886
[TBL] [Abstract][Full Text] [Related]
11. Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs.
Seibert CW; Rahmat S; Krause JC; Eggink D; Albrecht RA; Goff PH; Krammer F; Duty JA; Bouvier NM; GarcĂa-Sastre A; Palese P
J Virol; 2013 Jul; 87(14):7793-804. PubMed ID: 23698296
[TBL] [Abstract][Full Text] [Related]
12. IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody.
Saito S; Sano K; Suzuki T; Ainai A; Taga Y; Ueno T; Tabata K; Saito K; Wada Y; Ohara Y; Takeyama H; Odagiri T; Kageyama T; Ogawa-Goto K; Multihartina P; Setiawaty V; Pangesti KNA; Hasegawa H
PLoS Pathog; 2019 Jan; 15(1):e1007427. PubMed ID: 30605488
[TBL] [Abstract][Full Text] [Related]
13. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
[TBL] [Abstract][Full Text] [Related]
14. Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.
Feng J; Zhang M; Mozdzanowska K; Zharikova D; Hoff H; Wunner W; Couch RB; Gerhard W
Virol J; 2006 Dec; 3():102. PubMed ID: 17150104
[TBL] [Abstract][Full Text] [Related]
15. The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure.
Kitikoon P; Strait EL; Thacker EL
Vet Microbiol; 2008 Jan; 126(1-3):51-62. PubMed ID: 17719187
[TBL] [Abstract][Full Text] [Related]
16. Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice.
Kolpe A; Schepens B; Ye L; Staeheli P; Saelens X
Antiviral Res; 2018 Oct; 158():244-254. PubMed ID: 30179634
[TBL] [Abstract][Full Text] [Related]
17. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.
Renegar KB; Small PA; Boykins LG; Wright PF
J Immunol; 2004 Aug; 173(3):1978-86. PubMed ID: 15265932
[TBL] [Abstract][Full Text] [Related]
18. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice.
Palladino G; Mozdzanowska K; Washko G; Gerhard W
J Virol; 1995 Apr; 69(4):2075-81. PubMed ID: 7884853
[TBL] [Abstract][Full Text] [Related]
19. IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration.
Terauchi Y; Sano K; Ainai A; Saito S; Taga Y; Ogawa-Goto K; Tamura SI; Odagiri T; Tashiro M; Fujieda M; Suzuki T; Hasegawa H
Hum Vaccin Immunother; 2018 Jun; 14(6):1351-1361. PubMed ID: 29425074
[TBL] [Abstract][Full Text] [Related]
20. Two Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding Antibody.
Chai N; Swem LR; Reichelt M; Chen-Harris H; Luis E; Park S; Fouts A; Lupardus P; Wu TD; Li O; McBride J; Lawrence M; Xu M; Tan MW
PLoS Pathog; 2016 Jun; 12(6):e1005702. PubMed ID: 27351973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]